{"title":"Remote monitoring of leadless pacemakers using a novel conductive telemetry communication method.","authors":"Sri Sundaram, Nitika Chellappa, Kunal Chaniary, Monica Lo, Devi Nair, Rajesh Banker","doi":"10.1007/s10840-025-02095-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Remote care has become part of the standard of care for cardiac rhythm device management. The Aveir™ single-chamber (AR and VR) and dual-chamber (DR) leadless pacemaker (LP) systems (Abbott, Abbott Park, IL) utilize a novel conductive telemetry communication schema for device interrogation and programming. A patient transmitter is designed as an at-home remote monitoring solution that interrogates the Aveir leadless pacemaker system via conductive telemetry and transmits the patient data.</p><p><strong>Objective: </strong>To characterize the performance of a remote care system that interrogates implanted Aveir LP systems via conductive telemetry.</p><p><strong>Methods: </strong>Patients implanted with an Aveir DR, VR, or AR system were enrolled in a data collection study upon hospital IRB approval of the study. The study protocol included (1) in-clinic interrogation of the LP system using the patient transmitter in a controlled setting, in two modes of use (hand-held and wired modes); and (2) optional at-home interrogation using the patient transmitter.</p><p><strong>Results: </strong>Thirty-one (25 males/6 females) subjects in three centers completed in-clinic interrogation of their Aveir system using the patient transmitter in both modes of use. Eighteen subjects completed at-home interrogation. Transmitter performance was comparable between modes of use, and between in-clinic and at-home interrogation. In all subjects 31/31 (100%), end-to-end remote care system use was successful.</p><p><strong>Conclusion: </strong>The initial, real-world experience of utilizing an end-to-end remote care system with Aveir LP patients demonstrated feasibility of this technology to offer an at-home remote monitoring solution for leadless pacemaker patients via conductive telemetry (Funded by Abbott Laboratories; Clinical Trials.gov ID:NCT06542133).</p>","PeriodicalId":520675,"journal":{"name":"Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s10840-025-02095-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Remote care has become part of the standard of care for cardiac rhythm device management. The Aveir™ single-chamber (AR and VR) and dual-chamber (DR) leadless pacemaker (LP) systems (Abbott, Abbott Park, IL) utilize a novel conductive telemetry communication schema for device interrogation and programming. A patient transmitter is designed as an at-home remote monitoring solution that interrogates the Aveir leadless pacemaker system via conductive telemetry and transmits the patient data.
Objective: To characterize the performance of a remote care system that interrogates implanted Aveir LP systems via conductive telemetry.
Methods: Patients implanted with an Aveir DR, VR, or AR system were enrolled in a data collection study upon hospital IRB approval of the study. The study protocol included (1) in-clinic interrogation of the LP system using the patient transmitter in a controlled setting, in two modes of use (hand-held and wired modes); and (2) optional at-home interrogation using the patient transmitter.
Results: Thirty-one (25 males/6 females) subjects in three centers completed in-clinic interrogation of their Aveir system using the patient transmitter in both modes of use. Eighteen subjects completed at-home interrogation. Transmitter performance was comparable between modes of use, and between in-clinic and at-home interrogation. In all subjects 31/31 (100%), end-to-end remote care system use was successful.
Conclusion: The initial, real-world experience of utilizing an end-to-end remote care system with Aveir LP patients demonstrated feasibility of this technology to offer an at-home remote monitoring solution for leadless pacemaker patients via conductive telemetry (Funded by Abbott Laboratories; Clinical Trials.gov ID:NCT06542133).